Huandi Zhou

机构：Hebei Medical University, Second Hospital of Hebei Medical University · ORCID：0000-0002-2617-6157

发表论文 68 篇 · 总被引 4376 次 · h-index 18

代表论文

• Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy (2023 · Frontiers in Immunology · 被引 20)
• IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas (2023 · Scientific Reports · 被引 13)
• MELK is a prognostic biomarker and correlated with immune infiltration in glioma (2022 · Frontiers in Neurology · 被引 13)
• Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress (2022 · International Journal of Endocrinology · 被引 11)
• HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathway (2024 · Translational Oncology · 被引 10)
• A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma (2022 · Journal of Oncology · 被引 4)